SAS Output

21-AUG-2019 6:10

LEUK ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1318-ALL, Age 65+, Ph±, Blinatumomab 1 T 1 Induction: Ph- 44 31 0 0 0 0 0 06/30/2015 133 52
        2 Induction: Ph+/Ph-like   16 0 0 0 0 0      
            47 0 0 0 0 0      
 
    2 Y 3 Post-remission: Ph- 44 20 0 0 0 0 0 06/30/2015    
        4 Post-remission: Ph+/Ph-like   12 0 0 0 0 0      
            32 0 0 0 0 0      
 
    3 Y 5 Maintenance: Ph- 44 14 0 0 0 0 0 06/30/2015    
        6 Maintenance: Ph+/Ph-like   10 0 0 0 0 0      
            24 0 0 0 0 0      
 
  S1612-AML/MDS, Age 60+, Aza/Novel Therapeutics 1 T 0 FLT3 Testing 1670 113 34 0 0 0 0 02/02/2018 206 83
            113 34 0 0 0 0      
 
    2 T 1 Azacitidine 1670 26 8 0 0 0 0 02/02/2018    
        2 Azacitidine + Nivolumab   26 9 0 0 0 0      
        3 Azacitidine + Midostaurin   26 9 0 0 0 0      
            78 26 0 0 0 0      
 
  S1712-CML, Chronic Phase, TKI +/- Ruxolitinib 1 Y 1 Single Agent TKI 84 7 7 5 4 3 1 10/24/2018 164 64
        2 TKI + Ruxolitinib   4 4 3 1 1 1      
            11 11 8 5 4 2      
 
Yes A041701-AML, Age 60+, Conv Chemo +/- Uproleselan 0 E Total Registrations   6 6 6 6 1 0 06/10/2019 14 5
            6 6 6 6 1 0      
 
    1 E Total Registrations   4 4 4 4 1 0 06/10/2019    
            4 4 4 4 1 0      
 
  A041702-CLL, Stg I-IV, IO with IM versus IVO 0 E Total Registrations   13 13 13 10 4 0 03/04/2019 88 35
            13 13 13 10 4 0      
 
    1 E Total Registrations   8 8 8 5 2 0 03/04/2019    
            8 8 8 5 2 0      
 
  E1910-BCR-ABL-neg, B ALL, Blinatumomab 1 E Total Registrations   116 25 10 3 1 1 06/06/2014   80
            116 25 10 3 1 1      
 
  EA9161-CLL, untreated, IOV vs IO in younger pts 1 E Total Registrations   38 38 37 23 7 2 02/12/2019 194 76
            38 38 37 23 7 2      
 
No A041501-B-Cell ALL, Frontline Tx +/- Intuzumab Ozo 0 E Total Registrations   8 8 5 3 1 0 11/09/2018 170 59
            8 8 5 3 1 0      
 
    1 E Total Registrations   5 5 3 3 1 0 11/09/2018    
            5 5 3 3 1 0      
 
    2 E Total Registrations   3 3 2 2 2 0 11/09/2018    
            3 3 2 2 2 0      
 
  E1910-BCR-ABL-neg, B ALL, Blinatumomab 0 E Total Registrations   162 34 16 8 3 1 06/06/2014   80
            162 34 16 8 3 1      
 
    2 E Total Registrations   74 17 6 2 1 0 06/06/2014    
            74 17 6 2 1 0      
 
    3 E Total Registrations   62 17 8 4 1 0 06/06/2014    
            62 17 8 4 1 0      
 
    4 E Total Registrations   25 4 3 2 1 0 06/06/2014    
            25 4 3 2 1 0